This company has been marked as potentially delisted and may not be actively trading. RXi Pharmaceuticals (RXII) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock RXII vs. EGRX, PYRGF, NNVC, TAOX, IBIO, ETHZ, NBY, AEON, MTNB, and OBSVShould you be buying RXi Pharmaceuticals stock or one of its competitors? The main competitors of RXi Pharmaceuticals include Eagle Pharmaceuticals (EGRX), PyroGenesis Canada (PYRGF), NanoViricides (NNVC), Synaptogenix (TAOX), iBio (IBIO), Flag Ship Acquisition (ETHZ), NovaBay Pharmaceuticals (NBY), AEON Biopharma (AEON), Matinas Biopharma (MTNB), and ObsEva (OBSV). RXi Pharmaceuticals vs. Its Competitors Eagle Pharmaceuticals PyroGenesis Canada NanoViricides Synaptogenix iBio Flag Ship Acquisition NovaBay Pharmaceuticals AEON Biopharma Matinas Biopharma ObsEva RXi Pharmaceuticals (NASDAQ:RXII) and Eagle Pharmaceuticals (NASDAQ:EGRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk. Is RXII or EGRX more profitable? Eagle Pharmaceuticals has a net margin of 0.00% compared to RXi Pharmaceuticals' net margin of -4,990.20%. Eagle Pharmaceuticals' return on equity of 0.00% beat RXi Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets RXi Pharmaceuticals-4,990.20% -412.15% -179.54% Eagle Pharmaceuticals N/A N/A N/A Which has more risk and volatility, RXII or EGRX? RXi Pharmaceuticals has a beta of 2.07, meaning that its stock price is 107% more volatile than the S&P 500. Comparatively, Eagle Pharmaceuticals has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Which has higher valuation & earnings, RXII or EGRX? Eagle Pharmaceuticals has higher revenue and earnings than RXi Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRXi Pharmaceuticals$10K946.08-$12.45M-$4.20-0.51Eagle Pharmaceuticals$257.55M0.19$35.64MN/AN/A Does the media refer more to RXII or EGRX? In the previous week, RXi Pharmaceuticals' average media sentiment score of 0.00 equaled Eagle Pharmaceuticals'average media sentiment score. Company Overall Sentiment RXi Pharmaceuticals Neutral Eagle Pharmaceuticals Neutral Do institutionals & insiders believe in RXII or EGRX? 9.6% of RXi Pharmaceuticals shares are held by institutional investors. Comparatively, 85.4% of Eagle Pharmaceuticals shares are held by institutional investors. 1.0% of RXi Pharmaceuticals shares are held by insiders. Comparatively, 28.9% of Eagle Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryEagle Pharmaceuticals beats RXi Pharmaceuticals on 7 of the 9 factors compared between the two stocks. Get RXi Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RXII and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RXII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RXII vs. The Competition Export to ExcelMetricRXi PharmaceuticalsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.46M$850.45M$5.73B$10.31BDividend YieldN/A4.84%5.90%4.63%P/E Ratio-0.511.1775.8626.51Price / Sales946.0826.62528.72123.58Price / CashN/A19.5637.1760.46Price / Book2.816.5812.796.29Net Income-$12.45M-$4.18M$3.28B$270.51M RXi Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RXIIRXi PharmaceuticalsN/A$2.16+1.4%N/A-35.6%$9.46M$10K-0.51N/AGap UpEGRXEagle PharmaceuticalsN/A$3.21+5.9%N/A-11.9%$41.69M$257.55M0.00100Gap DownPYRGFPyroGenesis CanadaN/A$0.18-6.0%N/A-66.9%$35.11M$9.14M-2.9390Gap UpNNVCNanoViricides0.2163 of 5 stars$1.46+1.4%N/A-4.0%$23.47MN/A-2.0320Gap UpTAOXSynaptogenix0.071 of 5 stars$6.24-0.5%N/AN/A$21.86MN/A-0.314IBIOiBio1.6779 of 5 stars$0.83-2.6%$5.00+500.4%-56.1%$16.80M$375K-0.48100Short Interest ↑ETHZFlag Ship AcquisitionN/A$2.44flatN/AN/A$14.74MN/A0.007News CoverageGap UpNBYNovaBay Pharmaceuticals0.3969 of 5 stars$2.30-14.8%$0.85-63.0%+348.2%$13.40M$9.78M-0.0430Gap DownAEONAEON Biopharma3.1486 of 5 stars$0.75+3.2%$360.00+47,996.2%-98.5%$8.72MN/A4.165News CoverageShort Interest ↓MTNBMatinas Biopharma0.0801 of 5 stars$1.64-1.8%N/AN/A$8.34MN/A-0.3430Negative NewsShort Interest ↑Gap DownOBSVObsEvaN/AN/AN/AN/A$7.94MN/A0.0050 Related Companies and Tools Related Companies EGRX Alternatives PYRGF Alternatives NNVC Alternatives TAOX Alternatives IBIO Alternatives ETHZ Alternatives NBY Alternatives AEON Alternatives MTNB Alternatives OBSV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RXII) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RXi Pharmaceuticals Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share RXi Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RXII Stock Alerts